Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeanne M. Sisk
FDA Approved Drugs With Broad Anti-Coronaviral Activity Inhibit SARS-CoV-2 in Vitro
Related publications
Repurposing FDA-approved Drugs for Anti-Aging Therapies
Biogerontology
Aging
Gerontology
Geriatrics
The FDA-approved Gold Drug Auranofin Inhibits Novel Coronavirus (SARS-COV-2) Replication and Attenuates Inflammation in Human Cells
Scutellaria Baicalensis Extract and Baicalein Inhibit Replication of SARS-CoV-2 and Its 3c-Like Protease in Vitro
Appendix: Representative Compounds With Inhibitory Activity Against SARS CoV or Other CoVs in Vitro
Quantitative Analysis on the Characteristics of Targets With FDA Approved Drugs
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
Possible FDA-approved Drugs to Treat Ebola Virus Infection
Infectious Diseases of Poverty
Medicine
Environmental
Public Health
Infectious Diseases
Occupational Health
SARS-COV-2 and Infectivity
Journal of Medical Virology
Virology
Infectious Diseases
The FDA-approved Anti-Cancer Drugs, Streptozotocin and Floxuridine, Reduce the Virulence of Staphylococcus Aureus
Scientific Reports
Multidisciplinary
Open Questions for Harnessing Autophagy-Modulating Drugs in the SARS-CoV-2 War